Literature DB >> 22555038

The role of radiotherapy in urinary bladder cancer: current status.

Gustavo Nader Marta1, Samir Abdallah Hanna, Rafael Gadia, Sebastiao Francisco Miranda Correa, Joao Luis Fernandes da Silva, Heloisa de Andrade Carvalho.   

Abstract

The role of radiotherapy (RT) in the treatment of urinary bladder cancer has undergone several modifications along the last decades. In the beginning, definitive RT was used as treatment in an attempt to preserve the urinary bladder; however, the results were poor compared to those of radical surgery. Recently, many protocols have been developed supporting the use of multi-modality therapy, and the concept of organ preservation began to be reconsidered. Although phase III randomized clinical studies comparing radical cystectomy with bladder preservation therapies do not exist, the conservative treatment may present low toxicity and high indexes of complete response for selected patients. The aim of this study was to review the literature on the subject in order to situate RT in the current treatment of urinary bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555038     DOI: 10.1590/s1677-55382012000200002

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  20 in total

1.  Radiotherapy in muscle-invasive bladder cancer: the latest research progress and clinical application.

Authors:  Shuo Zhang; Yong-Hua Yu; Yong Zhang; Wei Qu; Jia Li
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.

Authors:  Junhao Lin; Yuchen Liu; Yonghao Zhan; Chengle Zhuang; Li Liu; Xing Fu; Wen Xu; Jianfa Li; Mingwei Chen; Zhiming Cai; Weiren Huang
Journal:  Tumour Biol       Date:  2015-10-01

3.  Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.

Authors:  Cheng-Le Zhuang; Xing Fu; Li Liu; Yu-Chen Liu; Wei-Ren Huang; Zhi-Ming Cai
Journal:  Tumour Biol       Date:  2015-02-10

4.  MiR-22 suppresses the growth and metastasis of bladder cancer cells by targeting E2F3.

Authors:  Junsheng Guo; Jian Zhang; Tianxiao Yang; Wei Zhang; Mingyang Liu
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

5.  Synthetic Tet-inducible artificial microRNAs targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and 5637.

Authors:  Yonghao Zhan; Yuchen Liu; Junhao Lin; Xing Fu; Chengle Zhuang; Li Liu; Wen Xu; Jianfa Li; Mingwei Chen; Guoping Zhao; Weiren Huang; Zhiming Cai
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

6.  shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells.

Authors:  Jianfa Li; Chengle Zhuang; Yuchen Liu; Mingwei Chen; Qing Zhou; Zhicong Chen; Anbang He; Guoping Zhao; Yinglu Guo; Hanwei Wu; Zhiming Cai; Weiren Huang
Journal:  Oncotarget       Date:  2016-05-17

7.  Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells.

Authors:  Yuchen Liu; Yonghua Han; Hu Zhang; Liping Nie; Zhimao Jiang; Pingping Fa; Yaoting Gui; Zhiming Cai
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

8.  Multi-modality organ-based approach to expected imaging findings, complications and recurrent tumour in the genitourinary tract after radiotherapy.

Authors:  Nicola Schieda; Shawn Christopher Malone; Omran Al Dandan; Parvati Ramchandani; Evan S Siegelman
Journal:  Insights Imaging       Date:  2013-11-26

9.  Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.

Authors:  Yonghao Zhan; Junhao Lin; Yuchen Liu; Mingwei Chen; Xiaoying Chen; Chengle Zhuang; Li Liu; Wen Xu; Zhicong Chen; Anbang He; Qiaoxia Zhang; Xiaojuan Sun; Guoping Zhao; Weiren Huang
Journal:  J Exp Clin Cancer Res       Date:  2016-05-20

10.  A Tumor-specific MicroRNA Recognition System Facilitates the Accurate Targeting to Tumor Cells by Magnetic Nanoparticles.

Authors:  Yingting Yu; Yi Yao; Hao Yan; Rui Wang; Zhenming Zhang; Xiaodan Sun; Lingyun Zhao; Xiang Ao; Zhen Xie; Qiong Wu
Journal:  Mol Ther Nucleic Acids       Date:  2016-05-03       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.